Search companies

Live

Tuesday, 17 November 2026 · 580 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Terragen’s Feedlot Trial Advances As Brazil Approves Probiotic Feed Additive

TGH: $0.014 +0.00% · MC: $12M

Terragen says its large-scale feedlot trial involving up to 10,600 cattle is progressing, with the animal trial expected to conclude in December and independent results due in March 2027; a separate supply agreement remains conditional, with first deliveries expected late this year. Brazil approved Terragen Probiotic as a feed additive, while cash and cash equivalents stood at approximately $6 million at quarter-end. The update also follows this week’s CEO departure: Joss West has taken over as interim CEO, and Daniel Pearce has agreed to remain CFO.

Source announcements: 2026-10-30 10:32 to 2026-10-30 10:32 Sydney time
Story updated 2026-10-30 10:40 Sydney time
SourcesQuarterly Activities/Appendix 4C Cash Flow Report
Comments